Free provider profile

OLGA OLEVSKY, M.D.

NPI 1841306743
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like OLGA OLEVSKY?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What OLGA OLEVSKY prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Ibrance
  • Verzenio
  • Jakafi
  • Lenvima
  • Kisqali

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

310-829-5471

Fax

310-582-7946

Practice address

2020 SANTA MONICA BLVD STE 230, SANTA MONICA, CA, 90404

Registry updated
2025-02-13
NPI issued
2006-08-22
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

2020 SANTA MONICA BLVD STE 230, SANTA MONICA, CA, 90404

310-829-5471

Single practice location

Enumerated 2006-08-22

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record updated within the last three years.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,226

Medicare patients

231

Part D drug cost

$3,177,553

Brand-name share

Not published

of this prescriber's Part D claims

DrugClaimsMedicare cost
Verzenio (Abemaciclib)34$522,073
Ibrance (Palbociclib)35$510,116
Lenvima (Lenvatinib Mesylate)15$368,643
Jakafi (Ruxolitinib Phosphate)18$316,628
Kisqali (Ribociclib Succinate)14$233,435
Calquence (Acalabrutinib Maleate)14$213,856
Brukinsa (Zanubrutinib)11$144,745
Inqovi (Decitabine/Cedazuridine)12$93,947

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across CA — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.